中药单体对眼部新生血管性疾病治疗作用的研究现状  

Research progress on inhibition of ocular neovascularization by traditional Chinese medicine monomers

作　　者：褚文丽 陈水龄 亢泽峰[1] 李维义 刘健[1] Wen-Li Chu;Shui-Ling Chen;Ze-Feng Kang;Wei-Yi Li;Jian Liu(Ophthalmic Hospital,China Academy of Chinese Medical Science,Beijing 100040,China)

机构地区：[1]中国中医科学院眼科医院,中国北京市100040

出　　处：《国际眼科杂志》2019年第2期236-239,共4页International Eye Science

基　　金：国家自然科学基金资助项目(No.81574032)~~

摘　　要：概述中药单体在眼部新生血管性疾病中的应用现状。通过检索近十余年来国内外相关研究文献,进行归纳和总结,概述中药单体抑制眼内新生血管的研究进展,阐述中医药在眼内新生血管研究领域具有的潜在优势,为眼部新生血管性疾病的研究及治疗提供新的思路和参考。Overview of the status application of traditional Chinese medicine monomers in ocular neovascular diseases.Through retrieving related domestic and overseas research state for more than ten years,summarizing,analyzing and summarizing,overviewing the research progress of traditional Chinese medicine monomer in inhibiting intraocular neovascularization,and expounding the potential advantages of traditional Chinese medicine in the field of intraocular angiogenesis research,providing information for treating and researching of neovascular diseases.

关 键 词：中药单体 新生血管 眼科 治疗作用 

分 类 号：R276.7[医药卫生—中医五官科学]